News

Buprenorphine/naloxone moves from Type 1 to Type 2 TPP drug

July 24, 2019

Change will be effective July 15, 2019.

July 24, 2019

Lessons Learned: Honesty, integrity, and record keeping are fundamental for dealings with third-party insurers.

July 24, 2019

Patient and prescriber information should never be shared on social media.

July 24, 2019

Recent announcements serve as a good reminder to stay informed.

July 24, 2019

Check out our mobile-friendly, digital report for highlights of how ACP supported effective and safe pharmacy practice.

July 24, 2019

Third-year U of A student Dillon Lee earns ACP’s Leadership Development Award.

July 24, 2019

The hearing decision involving Mohamed Elsayed Haggag is now available.

July 23, 2019

Hearing Status:	Decision pending
Registrant:	Si Huu Nguyen, registration number 4718
...

July 23, 2019

Hearing Status:	Decision pending
Registrant:	Moustafa Alrefaey, registration number 11234 ...

July 10, 2019

New tool from ACP supports gap analysis to meet the standards.

July 10, 2019

Licensees must ensure pharmacists and pharmacy technicians on staff are regulated.

July 10, 2019

Pharmacies can play a role in harm reduction.

July 10, 2019

Former pharmacist and patient safety officer Linda Poloway overwhelmed by prestigious award.